Abstract

Objective Autoimmune thyroid diseases (AITD), mainly Graves' disease (GD) and Hashimoto's thyroiditis (HT), are common organ-specific autoimmune diseases characterized by circulating antibodies and lymphocyte infiltration. Follicular helper T (Tfh) cell dysregulation is involved in the development of autoimmune pathologies. We aimed to explore the role of intrathyroidal and circulating Tfh cells in patients with GD and HT. Methods Ultrasound-guided thyroid fine-needle aspiration (FNA) was conducted in 35 patients with GD, 40 patients with HT, and 22 patients with nonautoimmune thyroid disease (nAITD). Peripheral blood samples were also obtained from 40 patients with GD, 40 patients with HT, and 40 healthy controls. The frequencies of intrathyroidal and circulating Tfh cells from FNA and peripheral blood samples were assessed by flow cytometry. Additionally, the correlations between the frequencies of the Tfh cells and the levels of autoantibodies and hormones or disease duration were analyzed. Results The frequency of intrathyroidal CD4+CXCR5+ICOShigh Tfh cells was higher in HT patients than in GD patients. Significant correlations were identified between the percentages of circulating and intrathyroidal Tfh cells and the serum concentrations of thyroid autoantibodies, especially thyroglobulin antibodies (TgAb), in AITD. Intrathyroidal CD4+CXCR5+ICOShigh Tfh cells were positively correlated with free triiodothyronine (FT3) in HT patients but negatively correlated with FT3 in GD patients. In addition, HT patients with a longer disease duration had an increased frequency of intrathyroidal CD4+CXCR5+ICOShigh and CD4+CXCR5+PD-1+ Tfh cells. In contrast, in the GD patients, a longer disease duration did not affect the frequency of intrathyroidal CD4+CXCR5+ICOShigh but was associated with a lower frequency of CD4+CXCR5+PD-1+ Tfh cells. Conclusions Our data suggest that intrathyroidal Tfh cells might play a role in the pathogenesis of AITD and they are potential immunobiomarkers for AITD.

Highlights

  • Graves’ disease (GD) and Hashimoto’s thyroiditis (HT) are autoimmune thyroid diseases (AITD) that are characterized by the accumulation of B and T lymphocytes in the thyroid gland and the production of autoantibodies targeting the thyroid [1–3]

  • The frequency of CD4+CXC chemokine receptor 5 (CXCR5)+ T cells was significantly increased in HT patients compared with healthy controls (P = 0:0092) (Figure 1(b)), whereas the frequencies of CD4+CXCR5+programmed death-1 (PD-1)+ and CD4+CXCR5+ICOShigh Tfh cells were comparable among these groups (Figures 1(c) and 1(d))

  • Tfh cells can play an important role in the promotion of autoimmune diseases [25, 26] as well as in the pathogenesis of AITD

Read more

Summary

Introduction

Graves’ disease (GD) and Hashimoto’s thyroiditis (HT) are autoimmune thyroid diseases (AITD) that are characterized by the accumulation of B and T lymphocytes in the thyroid gland and the production of autoantibodies targeting the thyroid [1–3]. Both GD and HT share the immunologic manifestation of the presence of circulating autoantibodies such as thyrotropin receptor autoantibodies (TRAb), thyroid peroxidase autoantibodies (TPOAb), and thyroglobulin autoantibodies (TGAb) [4]. Tfh cells have been well investigated in many autoimmune diseases, such as systemic lupus erythematosus (SLE), Journal of Immunology Research

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call